1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Vitaz: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma Dendritic cell vaccination, Atezolizumab, Platinum/pemetrexed based chemotherapy - Malignant Pleural Mesothelioma | Phase 1 / Phase 2 | Recruiting | University Hospital, Antwerp | 15 | 2023-02-24 | 2026-06-05 |
Mesothelioma, Malignant (1) · Wilms Tumor (1)
Platinum (1) · atezolizumab (1)
Belgium (1)
Koen Deschepper, MD (1) · Zwi N Berneman, MD, PhD (1)